Claim: In phase 3 clinical trial Triumph 4, at 68 weeks, those on 12 milligrams of Retatrutide lost about 29% of their body weight.
Verdict: Partially True (65% confidence)
Explanation: According to GLP-3 Wiki, the TRIUMPH-4 trial reported a 28.7% mean weight loss at 12 mg over 68 weeks, which is noted as the largest reported in any Phase 3 obesity trial to date. Pharmaphorum mentions that the 28.7% weight reduction was recorded after 68 weeks of treatment with the 12 mg dose of retatrutide. Patientcareonline also reports that the 12 mg dose met all endpoints with a 28.7% weight loss. However, while these sources provide information about the trial's findings, they do not const...